Molecular pathogenesis of theiler’s murine encephalomyelitis virus-induced demyelinating disease in mice

Intervirology

Volumn 40, Issue 2-3, 1997, Pages 143-152

  Lipton, Howard L ^a   Jelachich, Mary Lou ^a,b  

^a EVANSTON HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Demyelination; Immunopathology; Macrophages; Picornavirus; Viral persistence

Indexed keywords

MYELIN;

DEMYELINATING DISEASE; HELPER CELL; MACROPHAGE; MOLECULAR BIOLOGY; MOUSE; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; REVIEW; VIRUS CAPSID; VIRUS MUTANT; VIRUS PATHOGENESIS; VIRUS RECOMBINANT; WHITE MATTER;

ANIMALS; DEMYELINATING DISEASES; GENE EXPRESSION; HUMANS; MICE; POLIOMYELITIS; RNA, VIRAL; THEILOVIRUS; VIRION; VIRUS LATENCY;

MIRIDAE; MURINAE; NEPTUNIA; PICORNAVIRIDAE; RNA VIRUSES; THEILER'S ENCEPHALOMYELITIS VIRUS;

EID: 0031451505     PISSN: 03005526     EISSN: 14230100     Source Type: Journal    
DOI: 10.1159/000150541     Document Type: Article

References (67)

1. Thciler M: Spontaneous encephalomyelitis of mice - A new virus disease, Science 1934:80: 122.
2. Thciler M: Studies on poliomyelitis, Medicine 1941:20:443-462.
3. Ha-Lee YM, Dillon K, Kosaras B, Sidman R, Rcvell P, Fujinami R, Chow M: Mode of spread to and within the central nervous system after oral infection of neonatal mice with the DA strain of Theilcr's murine encephalomyelitis virus, J Virol 1995;69:7354-7361.
4. Pevear DC, Calenof TM, Rozhon E, Lipton HL: Analysis of the complete nucleotide sequence of the picomavirus Theiler's murine encephalomyelitis virus indicates that it is closely related to cardioviruscs, J Virol 1987:61:1507-1516.
5. Pevear DC, Borkowski J, Luo M, Liplon H: Sequence comparison of a highly virulent and a less virulent strain of Theiler's virus, Amino acid differences on a three-dimensional model identify the location of possible immunogenic sites, Ann NY Acad Sei 1988:540:652-653.
6. Ohara Y, Stein S, Fu J, Stillman L, Klaman L, Roos RP: Molecular cloning and sequence determination of DA strain of Theiler's murine encephalomyelitis virus, Virology 1988:164: 245-255.
7. Luo M, Cunheng H, Toth KS, Zhang CX, Lip-ton HL: Three-dimensional structure of Theiler's murine encephalomyelitis virus (BeAn slrain), Proc Natl Acad Sci USA 1992;89: 2409-2413.
8. Grant RA, l ilman DJ, Fujinami RS, lcenogle JP, Hogle JM: Three-dimensional structure of Theiler's virus, Proc Natl Acad Sci USA 1992: 89:2061-2065.
9. Luo M, Toth KS, Zhou 1., Pritchard A, Lipton HL: The structure of a highly virulent Theiler’s murine encephalomyelitis virus (GDVII) and implications for determinants of viral persistence, Virology 1995:220:246-250.
10. Nitavaphan S, Toth MM, Roos RP: Neutralizing monoclonal antibodies to Theilcr's murine encephalomyelitis virus, J Virol 1985:53:651-657.
11. Zurbriggen A, Fujinami RS: A neutralization-resistant Theilcr's virus variant produces an altered disease pattern in the mouse central nervous system, J Virol 1989;63:1505-1513.
12. Sato S, Zhang L, Kim J, Jakob J, Grant RA, Wollmann R, Roos RP: A neutralization site of DA strain of Theiler's murine encephalo-mye-litis virus important for disease phenotype, Virology 1996:226:327-337.
13. Lipion HL: Theiler’s virus infection in mice: An unusual biphasic disease process leading to demyclinalion, Infect Immun 1975; 11:1147-1155.
14. Dal Canto MC, Lipton HL: Primary demvelin-ation in Theilcr's virus infection, An ultrastruc-tural study, Lab Invest 1976;33:626-637.
15. Rodriguez M, Lcibowitz JL, Lampcrt PW: Persistent infection of oligodendrocytes in Theiler’s virus-induced encephalomyelitis, Ann Neurol 1983;13:426-433.
16. Blakemore WF, Welsh CJ, Tonks P, Nash AA: Observations on demyelinating lesions induced by Theilcr’s virus in CBA mice, Acta Neuropathol 1988;76:581-589.
17. Cash E, Chamorro M, Brahic M: Theiler's virus RNA and protein synthesis in the central nervous system of demyelinating mice, Virology 1985:144:290-294.
18. Cash E, Chamorro M, Brahic M: Minus-strand RNA synthesis in the spinal cords of mice persistently infected with Theiler's virus, J Virol 1988:62:1824-1826.
19. Clatch RJ, Miller SD, Metzncr R, Dal Canto MC, Lipton HL: Monocvtcs/macrophagcs isolated from the mouse central nervous system contain infectious Theiler's murine encephalomyelitis virus (TMEV), Virology 1990:176: 244-254.
20. Lipton HL, Twaddle G, Jelachich ML: The predominant virus antigen burden is present in macrophages in Theilcr’s murine encephalomyelitis virus TMEVj-induced demyelinating disease, J Virol 1995:69:2525-2533.
21. Rossi CP, Dclcroix M, Huitinga I, McAllister A, van Rooijen N, Claassen E, Brahic M: Role of macrophages during Theilcr's virus infection, J Virol 1997;71:3336-3340.
22. Jelachich ML, Lipton HL: Murine macrophage cell lines arc differentially susceptible to apop-tosis induced by Theiler's murine encephalomyelitis virus, In preparation.
23. Brahic M, Haase AT, Cash E: Simultaneous in situ detection of viral RNA and antigens, Proc Natl Acad Sci USA 1984:81:5445-5448.
24. Lipton HL, Dal Canto MC: Theiler's virus-induced dcmyclination: Prevention by immunosuppression, Science 1976:192:62-64.
25. Friedmann A, Frankcl G, Lorch Y, Steinman L: Monoclonal anti-l-A antibody reverses chronic paralysis and demyclination in Theiler's virus-infected mice: Critical importance of timing of treatment, J Virol 1987;61:898-903.
26. Rodriguez M, Sriram S: Successful therapy of Theilcr's virus-induced demvelination (DA strain) with monoclonal anti-Lyt-2 antibody, J Immunol 1988;140:2950-2955.
27. Miller SD, Gercty SJ: Immunologic aspects of Theiler’s murine encephalomyelitis virus (TMF, V)-indueed demyelinating disease, Semin Virol 1990:1:263-272.
28. Ficlle L, Aubert C, Brahic M, Rossi CP: Theiler's virus infection of beta 2-microglobulin-dcTicicnt mice, J Virol 1993:67:589-592.
29. Pullen M, Miller SD, Dal Canto MC, Kim BS: Class I deficient resistant mice intraecrcbrally inoculated with Theilcr’s virus show an increased T cell response to viral antigens and susceptibility to demyclination, Eur J Immunol 1993;23:2287-2293.
30. Rodriguez M, Dunkcl AJ, Thiemann RL, Lei-bowitz J, Zijlstra M, Jaenisch R: Abrogation of resistance to Theiler's virus-induced demyelin-ation in H-2b mice deficient in beta 2-microglobulin, J Immunol 1993:151:266-276.
31. Borrow P, Ionks P, Welsh CJ, Nash AA: The role of CDS' T cells in the acute and chronic phases of Theiler's murine encephalomyelitis virus-induced disease in mice, J Gen Virol 1992;73:1861-1865.
32. Gercty SJ, Rundell KM, Dal Canto MC, Miller SD: Class il-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease, VI, Potentiation ofde-myelination with and characterization of an immunopathologic CD4* T cell line specific for an immunodominant VP2 epitope, J Immunol 1994:152:919-929.
33. Karpus WJ, Pope JG, Peterson JD, Dal Canto MC, Miller SD: Inhibition of Theiler’s virus-mediated demyclination by peripheral immune tolerance induction, J Immunol 1995: 155:947-957.
34. Vanguri P, Shin ML: Hydrolysis of myelin basic protein in human myelin by terminal complement complexes, J Biol Chem 1988:263: 7228-7234.
35. Miller SD, Gercty SJ, Kennedy MK, Peterson JD, Trotter JL, Touhv VK,’ct al: Class-11 restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced de-myelinating disease, III, Failure of neuroanti-gen-specific immune tolerance to affect the clinical course of dcmyclination, J Neuroim-munol 1989;26:9-23.
36. Miller SD, Vanderlugt CL, Smith Begolka W, Pao W, Yauch RL, Neville KL, Katz-Levy Y, Kim BS: Persistent infection with Theiler's virus leads to myelin-specific autoimmunity via epitope spreading, Nat Med, submitted.
37. Calcnoff MA, Faaberg KS, Lipton HL: Genomic regions of neurovirulence and attenuation in Theiler's murine encephalomyelitis, Proc Natl Acad Sci USA 1990:87:978-982.
38. Fu J, Rodriguez M, Roos RP: Strains from both Theiler’s virus subgroups encode a determinant for demyclination, J Virol 1990:64:6345-6348.
39. McAllister A, Tangy F, Aubert C, Brahic M: Genetic mapping of the ability of Theiler's virus to persist and demyclinatc, J Virol 1990: 64:4252-4257.
40. Rodriguez M, Roos RP: Pathogenesis of early and late disease in mice infected with Theiler’s virus, using intratypic recombinant GDVII/ DA viruses, J Virol 1992:66:217-225.
41. Adami C, Pritchard AE, Knauf T, Luo M, Lipton HL: Mapping a determinant for central nervous system persistence in the capsid of murine encephalomyelitis virus (TMEV) with recombinant viruses, J Virol, in press.
42. Lipton HL: Persistent Theiler's murine encephalomyelitis virus infection in mice depends on plaque size, J Gen Virol 1980:46:169-177.
43. Pritchard AE, Jensen K, Lipton HL: Assembly of Theiler's virus recombinants used in mapping determinants of ncurovirulence, J Virol 1993:67:3901-3907.
44. Zhang L, Scnkowski A, Shim B, Roos RP: Chimera cDNA studies of Theiler's murine encephalomyelitis virus neurovirulence, J Virol 1993:65:4404-4408.
45. Filman DJ, Syed R, Chow M, Macadam AJ, Minor PD, Hogle JM: Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus, EMBO J 1989:8:1567-1579.
46. Pcvear DC, Oh CK, Cunningham LL, Calenoff M, Jubelt M: Localization of genomic regions specific for the attenuated mouse-adapted poliovirus type 2 strain W-2. J Gen Virol 1990:71: 43-52.
47. Ren RB, Moss EG, Racaniello VR: Identification of two determinants that attenuate vaccine-related type 2 poliovirus, J Virol 1991:65: 1377-1382.
48. C'aggana M, Chan P, Ramsingh A: Identification of a single amino acid residue in thecapsid protein VP1 of coxsackievirus B4 that determines the virulent phenotype, J Virol 1993:67: 4797-4803.
49. McAllister A, Tangv F, Aubert C, Brahic M: Molecular cloning of the complete genome of Theiler's virus, strain DA, and production of infectious transcripts, Microb Pathog 1989:7: 381-388.
50. Jarousse N, Grant RA, Hogle JM, Zhang L, Senkowski A, Roos RP, et al: A single amino acid change determines persistence of a chimeric Theiler's virus, J Virol 1994:68:3364-3368.
51. Zurbriggen A, Hogle JM, Fujinami RS: Alteration of amino acid 101 within capsid protein VP-1 changes the pathogenicity of Theiler’s murine encephalomyelitis virus, J Exp Med 1989:170:2037-2049.
52. Zurbriggen A, Thomas C, Yamada M, Roos RP, Fujinami RS: Direct evidence of a role for amino acid 101 ofVP-l in central nervous system disease in Theiler's murine encephalomyelitis virus infection, J Virol 1991:65:1929-1937.
53. Wada Y, Pierce ML, Fujinami RS: Importance of amino acid 101 within capsid protein VP1 for modulation of Theiler's virus-induced disease, J Virol 1994:68:1219-1223.
54. Peterson JD, Waltenbaugh C, Miller SD: IgG subclass responses to Theiler's murine encephalomyelitis virus infection and immunization suggest a dominant role for Till cells in susceptible mouse strains, Immunology 1992; 75:652-658.
55. Rossi CP, Cash E, Aubert C, Coutinho A: Role of the humoral immune response in resistance to Theiler’s virus infection, J Virol 1991:65: 3895-3899.
56. Cash E, Bandcira A, Chirinian S, Brahic M: Characterization of B lymphocytes present in the demyclinating lesions induced by Theiler's virus, J Immunol 1989:143:984-988.
57. Clatch RJ, Mclvold RW, Miller SD, Lipton HL: Theiler's murine encephalomyelitis virus (TMEV)-mduced demyclinating disease in mice is influenced by the H-2D region: Correlation with TMEV-spccific delayed type hyper sensitivity, J Immunol 1985:135:1408-1414.
58. Gerety SJ, Clatch RJ, Lipton HL, Goswami RG, Rundcll MK, Miller SD: Class Il-re-strictcd T cell responses in Theiler’s murine encephalomyelitis virus TMEVj-induced de-myclinating disease, IV, Identification of an immunodominant T cell determinant on the N-temiinal end of the VP2 capsid protein in suscep444tible SJL/J mice. J Immunol 1991:46: 2401-2408.
59. Gerety SJ, Karpus WJ, Cubbon AR, Goswami RG, Rundcll MK, Peterson JD, Miller SD: Class II-restrictcd T cell responses in Theiler’s murine encephalomyelitis virus-induced de-myelinating disease, V, Mapping of a dominant immunopathologic VP2 T cell epitope in susceptible SJL/J mice, J Immunol 1994:152:908-918.
60. Yauch RL, Kim BS: A predominant viral epitope recognized by T cells from the periphery and demyclinating lesions of SJL mice infected w ith Theiler’s virus is located within VP 1233-244. J Immunol 1994:153:4508-4519.
61. Yauch RL, Kerckcs K, Saujani K, Kim BS: Identification of a major T-cell epitope within VP3 amino acid residues 24 to 37 of Theiler's virus in dcmyelination-susceptiblc SJL/J mice, J Virol 1995:69:7315-7318.
62. Rozhon EJ, Kratochvil JD, Lipton HL: Analysis of genetic variation in Theiler's virus during persistent infection in the mouse central ner-voussystcm, Virology 1983:128:16-32.
63. Sethi P, Lipton HL: Location and distribution of virus antigen in the central nervous system of mice persistently infected with Theiler's virus, Br J Exp Pathol 1983:64:57-65.
64. Rodriguez M, Lucchinetti CF, Clark RJ, Ya-kash TL, Markow'itz H, Lcnnon VA: Immunoglobulins and complement in demyclination induced in mice by Theiler’s virus, J Immunol 1988;140:800-806.
65. Pritchard AE, Calenoff MA, Simpson S, Jensen K, Lipton HL: A single base deletion in the 5' noncoding region of Theiler’s virus attenuates ncurovirulence, J Virol 1992;66:1951-1958.
66. Calenoff MA, Badshah CS, Dal Canto MC, Lipton HL, Rundcll K: The leader polypeptide of Theiler's virus is essential for ncurovirulence but r, ol for virus growth in BHK cells, J Virol 1995:69:5549.
67. Bancyopadhyay PK, Pritchard A, Jensen K, Lipton HL: A three-nucleotide insertion in the H stcm-loop of the 5' untranslated region of Theiler’s virus attenuates neurovirulcncc, J Virol 1993:67:3691-3695.